PORTELA DIN 02563460
Status: Marketed
Holder: ZOETIS CANADA INC
Health Canada record
| Active ingredient(s) | RELFOVETMAB 6.4 MG |
|---|
| Dosage form | Solution |
|---|
| Route | Subcutaneous |
|---|
| Schedule | PRESCRIPTION RECOMMENDED |
|---|
| Class | Veterinary |
|---|
| ATC | |
|---|
| Original market date | 28-Apr-2026 |
|---|
| Current status date | 28-Apr-2026 |
|---|
| Source | Health Canada DPD |
|---|
Establishment licence of the holder
Zoetis Canada Inc — licence 102076, currently licensed, last inspection rating C (2023-10-05).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing RELFOVETMAB
| DIN | Product | Company | Form | Strength | Status |
|---|
| 02563452 | PORTELA | ZOETIS CANADA INC | Solution | RELFOVETMAB 2.5 MG | Marketed |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|
| 36471 | 2025-12-04 | New Drug Submission (NDS) | |
Request a quote for PORTELA
How to read a Canadian DIN record